Global Point of Care
Order the #1 COVID-19 self test in the US* by tapping your favorite place to shop below.
During the early stages of the pandemic, we helped pioneer the technology used on the frontlines to test for COVID-19.
Now that same technology is available to you in a convenient at-home testing kit.
Reliable COVID-19 results
in just 15 minutes.
The same technology doctors use to test for COVID-19.
Detects multiple variants.
During the early stages of the pandemic, we helped pioneer the technology used on the frontlines to test for COVID-19.
Now that same technology is available to you in a convenient at-home testing kit.
 | Reliable COVID-19 results in just 15 minutes. |
 | The same technology doctors use to test for COVID-19. |
 | Detects multiple variants. |
You don’t need to be a doctor to figure out the same technology doctors use to test for COVID-19.
Watch this video to see how the BinaxNOW COVID-19 Self Test goes down.
Open the test card and apply six drops to the top hole only.
Give both nostrils a shallow swab for about 15 seconds on each side. Big circles – no spinning!
Stick the swab through the
bottom hole into the top hole. Turn the swab to the right clockwise 3x. Fold the card.
Wait 15 minutes to see your reliable COVID-19 results.
Since the launch of the BinaxNOW™ COVID-19 Antigen Self Test, Abbott has continued testing for product stability to extend the expiration date and have shared these results with the FDA. Testing has been completed to support a shelf-life (expiration date) of up to 22 months. The BinaxNOW™ COVID-19 Antigen Self Test, part number 195-160 or 195- 180, may now have a longer than labeled product expiry date. All BinaxNOW COVID-19 Antigen Self Test kits currently have a twenty-two-month expiry date.
| KIT LOT NUMBER | ORIGINAL PRINTED EXPIRATION DATE^ | EXTENDED EXPIRATION DATE |
|---|
Disclaimer:
This tool is designed to offer a convenient way for consumers to lookup extended dating by lot number, utilizing information shared by Abbott with the FDA. For official information, please see the FDA letter listing BinaxNOW™ COVID-19 Antigen Self Test kit lot numbers, currently labeled kit expiry and new kit expiry date available on the FDA website at https://www.fda.gov/media/158003/download.
Note: do not use LOT number on individual kit components (test cards, nasal swabs, reagent bottles, instructions, or fact sheet)
Rapid tests are essential tools to help diagnose what’s behind your symptoms, so you can treat earlier and get well sooner. Understand the differences between rapid molecular tests and at home COVID-19 antigen self tests.
This program will teach you about rapid tests and how they can quickly identify illnesses like the flu, COVID-19, RSV, and strep throat. Rapid testing can help you get treated earlier and get well sooner.
Learn about respiratory illnesses and the newer advanced test technology that offers fast and accurate results. Knowing now means you’ll be treated earlier which can help you get well sooner.
Only available in the US. Terms of Sale.
The BinaxNOW™ COVID-19 Antigen Self Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARSCoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
*1H 2023 Nielsen Test Sales Market Data on file
**Abbott conducted a computational analysis of the detection of multiple SARS-COV-2 strains, including the OMICRON variant, and predicts no impact in the performance of our BinaxNOW COVID-19 Antigen Self Test.
^Some kits may have an additional label added that states “New expiry date. Disregard dates printed on components.” Original printed expiration date may be covered by this new label.
(COL-19286)
A Leader in Rapid Point-of-Care Diagnostics.
©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement | Declaration for California Compliance Law.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.